Risks of anticholinergic drugs

Adverse effects of drugs among the elderly should be given special attention when considering a pharmacological intervention.

Two recent papers using large electronic health records have explored the impact of drugs with anticholinergic properties.

The first, “Associations between Anticholinergic Burden and Adverse Health Outcomes in Parkinson Disease” view here used a HealthFacts database (Cerner Corporation, Kansas City, Missouri, USA) composed of 16,302 patients with Parkinson disease.

The second “Anticholinergic drugs and risk of dementia: case-control study” view here utilized 14,453 patients with dementia and 86,403 controls from the UK Clinical Practice Research Datalink.

Both studies observed a robust relationship between the use of drugs with anticholinergic properties and adverse consequences, including dementia, increased risks of visit to emergency departments and risk of fracture.  Both studies demonstrate the importance of large electronic health record systems in understanding adverse drug events.

Posted in

More RSI News

Dr. Mattison chairs NAM report

July 24, 2020
National Academy of Sciences review chaired by Dr. Mattison

Compounded medications prepared by pharmacists or physicians have been used extensively throughout history as a mainstay of therapeutics.  Over the past half-century – with the…

Read News Item

COVID-19 timeline by RSI

May 23, 2020
Screen grab of RSI's Covid-19 timeline

As part of its new Risk & Crisis Communication Master Class & Boot Camp, and its ongoing commitment to keep its understanding of major public…

Read News Item

Country Foods Forum

March 1, 2020
Cover of Health Canada, RSI-organized, Country Foods Forum highlights

Leading up to February 11 and 12, 2020, Risk Sciences International had the privilege of assisting Health Canada in its organization of the Country Foods…

Read News Item

Workshop on Evidence Integration December 5-6, 2019

November 11, 2019
RSI logo in white

Risk Sciences International is organizing a two day Workshop on Evidence Integration in support of human health risk assessment in collaboration with the McLaughlin Centre…

Read News Item